Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas

Leukemia

Volumn 27, Issue 8, 2013, Pages 1748-1750

  Miguet, L ^a,b   Lennon, S ^b,c   Baseggio, L ^d   Traverse Glehen, A ^d   Berger, F ^d   Perrusson, N ^b   Chenard, M P ^b   Galoisy, A C ^a   Eischen, A ^a   Mayeur Rousse, C ^b   Maar, A ^a   Fornecker, L ^a,b,c   Herbrecht, R ^a   Felman, P ^d   Van Dorsselaer, A ^b,d   Carapito, C ^b,d   Cianferani S ^b,d   Mauvieux, L ^a,b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c CNRS   (France)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD180 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; CELL SURFACE PROTEIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN D; LEUKOSIALIN; LYMPHOCYTE ANTIGEN; PROTEOME; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

B CELL LYMPHOMA; B LYMPHOCYTE; BLOOD CELL; BLOOD SAMPLING; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURFACE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; LETTER; MANTLE CELL LYMPHOMA; MASS SPECTROMETRY; NODAL MARGINAL ZONE LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; WALDENSTROEM MACROGLOBULINEMIA;

ANTIGENS, CD; ANTIGENS, SURFACE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOPROLIFERATIVE DISORDERS; NEOPLASTIC CELLS, CIRCULATING; SPLEEN;

EID: 84881481988     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.3     Document Type: Letter

References (12)

1. Baseggio L, Traverse-Glehen A, Petinataud F, Callet-Bauchu E, Berger F, Ffrench M et al. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases. Haematologica 2010; 95: 604-612.
2. Swerdlow SH, Campo E, Harris N, Jaffe ES, Pileri SA, Stein H et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, 2008.
3. Traverse-Glehen A, Baseggio L, Bauchu EC, Morel D, Gazzo S, Ffrench M et al. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity? Blood 2008; 111: 2253-2260. (Pubitemid 351454029)
4. Miguet L, Pacaud K, Felden C, Hugel B, Martinez MC, Freyssinet J-M et al. Pro-teomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics 2006; 6: 153-171. (Pubitemid 43142942)
5. Miguet L, Béchade G, Fornecker L, Zink E, Felden C, Gervais C et al. Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis. J Proteome Res 2009; 8: 3346-3354.
6. Miura Y, Miyake K, Yamashita Y, Shimazu R, Copeland NG, Gilbert DJ et al. Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64). Genomics 1996; 38: 299-304. (Pubitemid 27030118)
7. Miura Y, Shimazu R, Miyake K, Akashi S, Ogata H, Yamashita Y et al. RP105 is associated with MD-1 and transmits an activation signal in human B cells. Blood 1998; 92: 2815-2822. (Pubitemid 28469095)
8. Chaplin JW, Kasahara S, Clark EA, Ledbetter JA. Anti-CD180 (RP105) activates B cells to rapidly produce polyclonal Ig via a T cell and MyD88-independent pathway. J Immunol 2011; 187: 4199-4209.
9. Porakishvili N, Kulikova N, Jewell AP, Youinou PY, Yong K, Nathwani A et al. Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes. Br J Haematol 2005; 131: 313-319. (Pubitemid 43899663)
10. Gutiérrez NC, Ocio EM, de Las Rivas J, Maiso P, Delgado M, Fermiñán E et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia 2007; 21: 541-549.
11. Kiel MJ, Velusamy T, Betz BL, Zhao L, Weigelin HG, Chiang MY et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med 2012; 209: 1553-1565.
12. Rossi D, Trifonov V, Fangazio M, Bruscaggin A, Rasi S, Spina V et al. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med 2012; 209: 1537-1551.